Caspase 3 as a therapeutic target for regulation of intervertebral disc degeneration in rabbits

Hideki Sudo1, Akio Minami

  • 1Department of Advanced Medicine for Spine and Spinal Cord Disorders, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan. hidekisudo@yahoo.co.jp

Arthritis and Rheumatism
|February 10, 2011
PubMed
Abstract

Insights

Inhibiting caspase 3 (an enzyme involved in cell death) through small interfering RNA (siRNA) effectively reduced apoptosis in rabbit intervertebral disc cells, offering a potential treatment for disc degeneration.

Area of Science:

  • Biomedical Research
  • Cell Biology
  • Regenerative Medicine

Background:

  • Intervertebral disc degeneration (IDD) is a significant cause of back pain.
  • The precise mechanisms driving IDD are not fully understood.
  • Apoptosis, or programmed cell death, is implicated in the progression of IDD.

Purpose of the Study:

  • To investigate the potential of inhibiting caspase 3 to regulate apoptosis in the context of intervertebral disc degeneration.
  • To assess the antiapoptotic effects of caspase 3 small interfering RNA (siRNA) in a rabbit model of IDD.

Main Methods:

  • Rabbit nucleus pulposus cells were treated with caspase 3 siRNA in a serum-starved environment.
  • Alexa Fluor 555-labeled caspase 3 siRNA was injected into the intervertebral discs of rabbits using an anular needle puncture model.
  • Caspase 3 messenger RNA (mRNA) and protein levels were quantified.
  • Degenerative changes were evaluated using magnetic resonance imaging (MRI) and histology.
  • Apoptosis was assessed via TUNEL staining.

Main Results:

  • Caspase 3 siRNA transfection significantly reduced apoptosis in rabbit nucleus pulposus cells.
  • In vivo studies confirmed successful delivery and knockdown of caspase 3 mRNA and protein in the intervertebral discs.
  • MRI and histological analyses revealed significant suppression of degenerative changes in the caspase 3 siRNA group.
  • TUNEL staining demonstrated a marked decrease in apoptotic nucleus pulposus cells in the siRNA-treated group compared to controls.

Conclusions:

  • Caspase 3 knockdown is an effective strategy to inhibit apoptotic cell death in intervertebral disc cells.
  • Targeting caspase 3 presents a promising therapeutic avenue for managing intervertebral disc degeneration.